Despite the implication of IFN-Is in the pathogenesis of RA, intra-articular injections with IFN-α and intraperitoneal injection with IFN-β have been shown to prevent the occurrence or development of RA in wild-type mice or RA mouse models. This evidence concerns the gene IFNA2 and rheumatoid arthritis.